Security key
28176E108
Edwards Lifesciences Corp - Common Stock (EW)
CUSIP: 28176E108
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 494,404,816
- Total 13F value
- $46,545,398,964
- Share change
- -2,274,059
- Put/Call ratio
- 78%
- SEC-reported price per share
- $94.33
- Number of holders
- 1,271
- Value change
- -$181,795,991
- Number of buys
- 532
- Number of sells
- 548
- Shares outstanding
- 576,625,106
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
1,271
Top holders
10
EW full security history
Ownership snapshot
Full 13F holder table
Edwards Lifesciences Corp SEC filings
Edwards Lifesciences Corp company facts
Broader feeds
Ownership snapshot
Top reported holders of EW - Edwards Lifesciences Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F
Highest disclosed value: $4,283,292,307
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. has the largest disclosed position value at $4.28B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value
Top 5
BlackRock Finance, Inc.
$4.28B
VANGUARD GROUP INC
$4.28B
STATE STREET CORP
$2.23B
Capital International Investors
$2.13B
ALLIANCEBERNSTEIN L.P.
$1.69B
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$4,283,292,307
51,774,354 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$4,281,379,010
51,751,227 shares
|
— | 31 Mar 2023 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$2,229,171,790
26,945,202 shares
|
— | 31 Mar 2023 |
| Capital International Investors |
13F
Company
|
—
denominator unverified
|
$2,130,897,709
25,759,106 shares
|
— | 31 Mar 2023 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
—
denominator unverified
|
$1,691,453,899
20,445,472 shares
|
— | 31 Mar 2023 |
| Bank of New York Mellon Corp |
13F
Company
|
—
denominator unverified
|
$1,507,341,672
18,220,013 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,271
Shares
494,404,816
Rows available
1,271
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
1,232
Q2 2023 holders
1,271
Holder diff
39
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|